Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Public Citizen Predicts Heart Valve Problems with Belviq Weight-Loss Drug June 29, 2012 Irvin Jackson Add Your Comments Officials at the prominent consumer watchdog group, Public Citizen, panned the federal government’s decision to approve a new weight loss drug, Belviq, predicting that it may eventually be recalled due to reports of heart damage. According to a statement released by Public Citizen’s Health Research Group director, Dr. Sidney Wolfe, the FDA ignored critical safety data when they approved Belviq, an Arena Pharmaceuticals drug. While it is the first new weight loss drug approved by the FDA in a decade, Dr. Wolfe suggested that it is going to be associated with a number of serious side effects, and that it will eventually be removed from the market like a number of other previously-approved weight loss drugs. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In April, when an FDA advisory panel was considering what requirements to impose upon companies wanting to market new weight loss drugs, Wolfe pointed out that there have been four obesity drug recalls over the past 15 years, including fen-Phen, Dexatrim/Accutrim, Meridia and drugs containing ephedra. All involved an increased risk of cardiovascular events such as strokes, hypertension and heart attacks. Wolfe said that Belviq, which was approved this week by the FDA, would be no different. He noted that there were signs of heart valve problems in the drug’s clinical trials, and pointed out that the advisory panel could not rule out the risk of Belviq heart side effects. His statement came as a recommendation against the use of diet drugs was published in the Annals of Internal Medicine. That report notes that the U.S. Preventative Services Task Force has determined that there is no data showing people can keep the weight off after they discontinue diet medications. When the health risks of those drugs are factored into the equation, the task force concluded that it could not recommend that anyone be prescribed or use weight loss drugs. Behavioral intervention proved to be far more effective, the task force found, and recommended that behavioral intervention be the route doctors take with patients who are obese. It has been 13 years since the last weight loss drug, Xenical (orlistat 120mg), was approved in 1999. The lower dose Alli (orlistat 60mg) is an over-the-counter weight-loss drug that was approved in 2007. Both drugs are marketed by GlaxoSmithKline, PLC, though Xenical is manufactured by Roche. The FDA issued a liver injury warning for Xenical and Alli in May 2010. Last April, Public Citizen petitioned the FDA to recall Alli and Xenical from the market. Belviq’s approval came even as another weight loss drug, Qnexa, is under consideration for approval. That drug has been developed by Vivus Inc., and approval has been delayed amid concerns about the risk of birth defects from topiramate, an antiseizure drug contained in the new weight-loss medication, which is also the active pharmaceutical ingredient in Topamax. Last year, side effects of Topamax use during pregnancy were linked to an increased risk of cleft palate and cleft lip. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior legal and investigative journalist with more than 30 years of experience covering complex issues at the intersection of law, politics, and environmental policy. He began his reporting career in 1991 after graduating from Wayne. Tags: Alli, Belviq, Heart Disease, Meridia, Stroke, Weight Loss Pill, Xenical More Belviq Lawsuit Stories Belviq Settlement Discussions Underway, as Cases Put on Hold May 12, 2022 Belviq Colon Cancer Lawsuit Cleared To Move Forward Over Diet Drug Maker’s Failure to Warn March 17, 2022 Lawsuit Alleges Link Between Rare Form of Brain Cancer and Belviq Diet Pills February 3, 2022 1 Comments Warren July 21, 2012 Dr. Sidney Wolfe has ignored the extensive studies that show Belviq has NO heart valve problem. I find that most of the negative reports on Belviq are from people that do not know how to read the studies from Arena Pharmaceutical, Inc. that were given to the FDA. Dr. Sidney Wolfe is in complete disagreement with his peers that will prescribe Belviq without hesitation. Where was Dr. Sidney Wolfe when the FDA was about to approve Qsymia that has REMS and a long list of risks? Maybe that Dr. Sidney Wolfe has a vested interest in Qsymia. I have stock in ARNA because I believe in the safety of the products from a company that has integrity and not the hype of Wall Street. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: today) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025) Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: today) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025) Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: 3 days ago) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)
Belviq Colon Cancer Lawsuit Cleared To Move Forward Over Diet Drug Maker’s Failure to Warn March 17, 2022
Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: today) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)
Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: today) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)
Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: 3 days ago) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)